Variable | COR (95% CI) | P-value | AOR (95% CI) | P-value |
---|---|---|---|---|
Age | 0.98 (0.97, 0.99) | 0.012 | 0.99 (0.96, 1.02) | 0.52 |
CCI score | 0.86 (0.76, 0.98) | 0.034* | 0.72(0.51, 0.96) | 0.37 |
Medication burden in number | 0.78 (0.65, 0.94) | 0.012* | 0.80 (0.47, 1.35) | 0.41 |
Belief in medication means score | 0.62 (0.44, 0.89) | 0.010* | 0.59 (0.30, 1.16) | 0.13 |
Lung function test | ||||
 FEVs 1, percent predicted | 1.10 (1.06,1.14) | < 0.001 | 1.05 (1.00,1.10) | 0.023 |
 FVC 1, percent predicted | 1.12 (1.08,1.07) | < 0.001 | 1.08 (1.04,1.13) | < 0.001 |
Gender | ||||
 Male | 1.59 (1.10, 2.30) | 0.013* | 6.45(1.28,32.44) | 0.024* |
 Female | 1 |  | 1 |  |
Marital status | ||||
 Single | 3.54 (1.65, 7.61) | 0.001* | 0.04 (0.01, 1.28) | 0.075 |
 Married | 1.82 (1.06,3.09) | 0.028* | 3.63(1.28,10.28) | 0.015* |
 Divorced | 1.43 (0.54,3.80) | 0.46 | 1.43 (0.23, 9.04) | 0.71 |
 Window | 1 |  | 1 |  |
Educational level | ||||
 Informal education | 0.44(0.27, 0.74) | 0.002* | 1.22 (0.24, 6.24) | 0.814 |
 Low level | 0.48 (0.28, 0.80 | 0.005* | 0.86 (0.200, 3.73) | 0.814 |
 High level | 1 |  | 1 |  |
Occupation | ||||
 Government employer | 1.46 (0.869, 2.44) | 0.153 | 2.85(0.51, 16.02) | 0.23 |
 Private employer | 0.81 (0.44, 1.41) | 0.506 | 0.28(0.04, 1.91) | 0.20 |
 Homemaker | 0.50 (0.29, 0.87) | 0.014* | 0.39 (0.09, 1.62) | 0.19 |
 Farmer | 1 |  | 1 |  |
Biomass use | ||||
No | 1.82(1.01, 3.21) | 0.048* | 6.04(1.59,22.87) | 0.008* |
yes | 1 | Â | 1 | Â |
Year of onset | ||||
 <  12 years | 1.81 (1.19, 2.77) | 0.006* | 1.78 (0.96,4.77) | 0.22 |
 ≥ 12 year | 1 |  | 1 |  |
Exacerbation -Menstruation | ||||
 Yes | 2.05 (1.02, 4.12) | 0.045 | 1.55 (0.55, 4.32) | 0.405 |
 No | 1 |  | 1 |  |
Relationship with HCP | ||||
 Poor | 0.06 (0.02, 0.18) | 0.000** | 0.024(0.02, 0.23) | 0.001* |
 Good | 1 |  | 1 |  |
Information by HCP | ||||
 No | 0.48 (0.31, 0.73) | 0.001* | 1.28 (0.45, 3.60) | 0.64 |
 Yes | 1 |  | 1 |  |
Patient role of enablement | ||||
 Low | 0.24 (0.16, 0.36) | 0.000** | 0.19 (0.08, 0.49) | 0.001* |
 High | 1 |  | 1 |  |
Asthma severity | ||||
 Intermittent | 1.22 (0.51, 2.95) | 0.65 | 2.7 (0.21,35.2) | 0.443 |
 Mild persistent | 1.57 (0.84, 2.91) | 0.158 | 2.45 (0.27,22.1) | 0.424 |
 Moderate persistent | 1.35 (0.76, 2.40) | 0.299 | 2.2 (0.31,16.2) | 0.429 |
 Sever persistent R | 1 |  | 1 |  |
Asthma medication | ||||
ICS + SABA | 2.45 (0.571,10.56) | 0.21 | 1.19(0.09,16.2) | 0.89 |
Oral +SABA | 2.8 (0.55,14.23) | 0.20 | 4.2 (0.18,95) | 0.37 |
ICS + SABA+oral | 1.9 (0.42,9.02) | 0.39 | 6.3 (0.91,45) | 0.95 |
Nonsteroid+SABA | 1 | Â | 1 | Â |
Concurrent medication Class | ||||
 CVD | 0.79 (0.04,16.07) | 0.884 | 2.3(0.42,12.5) | 0.68 |
 Endocrine drug | 0.41(0.02, 8.30) | 0.558 | 2.5 (0.47,13.7) | 0.65 |
 GI Drug | 0.07 (0.002, 2.87) | 0.164 | 0.17(0.00, 1,24) | 0.49 |
 Antipain | 1.05 (0.05, 20.63 | 0.977 | 1.1 (0.45,26) | 0.952 |
 ART drugs | 1 |  | 1 |  |
Appropriateness of dose | ||||
 Optimal | 3.10 (2.04, 4.71) | 0.000** | 2.16 (0.86, 5.44) | 0.101 |
 Sub-optimal | 1 |  | 1 |  |
HCP adherence to our guidelines | ||||
 Yes | 4.87 (3.00, 7.89) | 0.001 | 8.4(2.70, 26.01) | 0.001** |
 No | 1 |  | 1 |  |
Appropriateness base on severity | ||||
 Yes | 4.19 (2.75, 6.38) | 0.00** | 2.02 (0.72, 5.70) | 0.18 |
 No | 1 |  | 1 |  |
Comorbidity | ||||
 Yes | 0.60 (0.42, 0.88) | 0.008* | 1.677 (0.487, 5.771) | 0.41 |
 No | 1 |  | 1 |  |
Adherence | ||||
 Low | 0.304 (0.17, 0.52) | 0.00** | 0.16 (0.059, 0.481) | 0.001** |
 High | 1 |  | 1 |  |